Oleksandr Karpenko
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Neuroendocrine Tumor Research Advances, Pancreatic and Hepatic Oncology Research, Atrial Fibrillation Management and Outcomes, Lung Cancer Research Studies
Most-Cited Works
- → A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors(2023)8 cited
- → FIGURE 3 from A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors(2023)
- → Data from A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors(2023)
- → TABLE 1 from A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors(2023)
- → FIGURE 4 from A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors(2023)
- → FIGURE 2 from A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors(2023)
- → TABLE 3 from A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors(2023)
- → Arrhythmias in patients of acute myocardial infarction and diabetes mellitus 2 type(2014)